CONMED Corp — Director's Dealing 2013

Jun 10, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-06-07

Reporting Person: SHALLISH ROBERT D JR (Vice President/Finance/CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-07	Common Stock	M	2000	$16.46	Acquired	45286	Direct
2013-06-07	Common Stock	F	1374	$32.38	Disposed	43912	Direct
2013-06-07	Common Stock	M	2800	$19.26	Acquired	46712	Direct
2013-06-07	Common Stock	F	2077	$32.38	Disposed	44635	Direct
2013-06-07	Common Stock	M	2800	$26.09	Acquired	47435	Direct
2013-06-07	Common Stock	F	2455	$32.38	Disposed	44980	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-07	Sars (Stock Appreciation Rights)	$16.46	M	2000	Disposed	2019-06-01	Common Stock (2000)	Direct
2013-06-07	Sars (Stock Appreciation Rights)	$19.26	M	2800	Disposed	2020-06-01	Common Stock (2800)	Direct
2013-06-07	Sars (Stock Appreciation Rights)	$26.09	M	2800	Disposed	2022-06-01	Common Stock (2800)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.